文献速递心律失常

心房颤动卒中预防中的左心耳封堵:现状与展望

Left atrial appendage closure for stroke prevention in atrial fibrillation: current status and perspectives.
PubMed 文献 · Eur Heart J · 2024-01-01

本文综述了左心耳封堵(LAAC)用于心房颤动(AF)患者卒中预防的现状。口服抗凝为当前标准治疗,LAAC 作为替代或补充手段;中等规模随机研究多与维生素K拮抗剂比较,装置迭代与影像技术提升其疗效和安全性。LAAOS III 显示心脏手术中同期外科 LAAC 在抗凝基础上降低卒中风险;多项比较 LAAC 与最佳药物治疗(含非维生素K拮抗剂口服抗凝药)的随机试验正在进行中。

要点

  • LAAC 可作为 AF 患者卒中预防的替代或补充治疗。
  • 现有随机证据多来自与维生素K拮抗剂的比较。
  • 心脏手术同期外科 LAAC 在抗凝基础上降低卒中风险。

核心结论

  • LAAC 是 AF 卒中预防中快速发展的替代或补充治疗,其疗效与安全性证据持续积累。

研究设计与样本

  • 综述,总结 LAAC 近期临床数据、正在进行的研究、开放问题与当前局限。

主要发现

  • 中等规模随机临床研究提供了导管 LAAC 疗效与安全性的数据,多与维生素K拮抗剂比较。
  • LAA 装置迭代、术前与围术期影像进步及植入技术持续提高 LAAC 的疗效与安全性。
  • LAAOS III 显示接受心脏手术的 AF 患者同期外科 LAAC 在抗凝治疗基础上降低卒中风险。

临床怎么用

  • 口服抗凝为当前标准治疗,LAAC 可作为替代或补充以减少卒中或系统性栓塞风险。

局限性

  • 多项比较 LAAC 与最佳药物治疗(含非维生素K拮抗剂口服抗凝药)的随机试验仍在进行中。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Atrial fibrillation (AF) is associated with an increased risk of stroke and systemic embolism, and the left atrial appendage (LAA) has been identified as a principal source of thromboembolism in these patients. While oral anticoagulation is the current standard of care, LAA closure (LAAC) emerges as an alternative or complementary treatment approach to reduce the risk of stroke or systemic embolism in patients with AF. Moderate-sized randomized clinical studies have provided data for the efficacy and safety of catheter-based LAAC, largely compared with vitamin K antagonists. LAA device iterations, advances in pre- and peri-procedural imaging, and implantation techniques continue to increase the efficacy and safety of LAAC. More data about efficacy and safety of LAAC have been collected, and several randomized clinical trials are currently underway to compare LAAC with best medical care (including non-vitamin K antagonist oral anticoagulants) in different clinical settings. Surgical LAAC in patients with AF undergoing cardiac surgery reduced the risk of stroke on background of anticoagulation therapy in the LAAOS III study. In this review, we describe the rapidly evolving field of LAAC and discuss recent clinical data, ongoing studies, open questions, and current limitations of LAAC.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Landmesser, Skurk, Tzikas, et al. Left atrial appendage closure for stroke prevention in atrial fibrillation: current status and perspectives. Eur Heart J. 2024. PMID: 39027946. doi:10.1093/eurheartj/ehae398

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。